Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome (eHUS).

Seminars in thrombosis and hemostasis - 1 Jun 2014

Würzner Reinhard, Riedl Magdalena, Rosales Alejandra, Orth-Höller Dorothea

Abstract excerpt

Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome (eHUS) still mostly relies on supportive intensive care regimens. Antibiotic treatment, as administered to eHUS patients during the 2011 O104:H4 outbreak, may reduce the shedding period, but this may apply only to this particular strain. In any case, there is no evidence for a beneficial use in the diarrheal phase and earlier...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adsorption
Share to Anti-Bacterial Agents
Share to Complement System Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Outbreaks

Share to Escherichia coli Infections

Share to Germany

Share to Hemolytic-Uremic Syndrome

Share to Plasma Exchange

Source

Identifiers

PMID: 24802085
DOI: 10.1055/s-0034-1375298

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome (eHUS).PMID 24802085Read ↗

Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging SequelaeSemantic proximity Read ↗

Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)Semantic proximity Read ↗

Enteropathogenic and EnterohemorrhagicEscherichia coliInfections: Emerging Themes in Pathogenesis and PreventionSemantic proximity Read ↗

Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.Semantic proximity Read ↗

Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics.Semantic proximity Read ↗

Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic SyndromeSemantic proximity Read ↗

Genetics, Toxicity, and Distribution of Enterohemorrhagic Escherichia coli HemolysinSemantic proximity Read ↗

Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 StrainSemantic proximity Read ↗

Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.Semantic proximity Read ↗

Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrheaSemantic proximity Read ↗

Eculizumab and drug-induced haemolytic-uraemic syndromeSemantic proximity Read ↗

Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic<i>Escherichia coli</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.